MME and breast carcinoma: CD10+GPR77+ CAFs are predictive for response to chemotherapy and patient survival, particularly in breast tumors with a high grade.40 The authors showed that the disease‐free survival of breast cancer patients with a high CD10+GPR77+ CAF infiltration was significantly shorter.